SpringWorks Therapeutics Net Income
| SWTXDelisted Stock | USD 46.99 0.00 0.00% |
As of the 20th of February, SpringWorks Therapeutics has the Semi Deviation of 2.82, risk adjusted performance of 0.0237, and Coefficient Of Variation of 4771.39. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of SpringWorks Therapeutics, as well as the relationship between them.
SpringWorks Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing SpringWorks Therapeutics' valuation are provided below:SpringWorks Therapeutics does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. SpringWorks |
Search Suggestions
| SW | Smurfit WestRock plc | Company |
| SWZ | Swiss Helvetia Closed | Fund |
| SWP | SWP Growth Income | ETF |
| SWRV | SWRV | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, SpringWorks Therapeutics reported net income of (258.13 Million). This is 175.64% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 145.21% higher than that of the company.
SpringWorks Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SpringWorks Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SpringWorks Therapeutics could also be used in its relative valuation, which is a method of valuing SpringWorks Therapeutics by comparing valuation metrics of similar companies.SpringWorks Therapeutics is currently under evaluation in net income category among its peers.
SpringWorks Fundamentals
| Return On Equity | -0.52 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (1.16) % | |||
| Operating Margin | (1.64) % | |||
| Current Valuation | 3.26 B | |||
| Shares Outstanding | 75.35 M | |||
| Shares Owned By Insiders | 1.20 % | |||
| Shares Owned By Institutions | 87.40 % | |||
| Number Of Shares Shorted | 6.38 M | |||
| Price To Earning | 6.14 X | |||
| Price To Book | 8.49 X | |||
| Price To Sales | 16.12 X | |||
| Revenue | 191.59 M | |||
| Gross Profit | 204.8 M | |||
| EBITDA | (278.13 M) | |||
| Net Income | (258.13 M) | |||
| Cash And Equivalents | 334.54 M | |||
| Cash Per Share | 6.81 X | |||
| Total Debt | 7.91 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 9.80 X | |||
| Book Value Per Share | 5.57 X | |||
| Cash Flow From Operations | (175.6 M) | |||
| Short Ratio | 1.46 X | |||
| Earnings Per Share | (3.41) X | |||
| Target Price | 47.0 | |||
| Number Of Employees | 368 | |||
| Beta | 0.7 | |||
| Market Capitalization | 3.54 B | |||
| Total Asset | 587.28 M | |||
| Retained Earnings | (1.15 B) | |||
| Working Capital | 280.48 M | |||
| Current Asset | 29.13 M | |||
| Current Liabilities | 10.16 M | |||
| Net Asset | 587.28 M |
About SpringWorks Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SpringWorks Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SpringWorks Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SpringWorks Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in SpringWorks Stock
If you are still planning to invest in SpringWorks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SpringWorks Therapeutics' history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |